Guidance

Predetermined Change Control Plans for Machine Learning-Enabled Medical Devices: Guiding Principles

Guiding principles for the use of Predetermined Change Control Plans (PCCPs) for managing rapid product changes.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 24 October 2023

Documents

Predetermined Change Control Plans for Machine Learning-Enabled Medical Devices: Guiding Principles

HTML

Predetermined Change Control Plans for Machine Learning-Enabled Medical Devices: Guiding Principles

PDF, 280 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The U.S. Food and Drug Administration (FDA), Health Canada, and the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) have jointly identified 5 guiding principles for the use of Predetermined Change Control Plans (PCCPs). PCCPs provide a new method for managing rapid product changes often seen with Software and Artificial Intelligence products. These guiding principles will help to ensure alignment between our jurisdictions on PCCPs and products utilising them.

Published 24 October 2023